BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15140423)

  • 1. The complex effects of leptin on bone metabolism through multiple pathways.
    Thomas T
    Curr Opin Pharmacol; 2004 Jun; 4(3):295-300. PubMed ID: 15140423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is leptin the link between fat and bone mass?
    Thomas T; Burguera B
    J Bone Miner Res; 2002 Sep; 17(9):1563-9. PubMed ID: 12211425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular clock mediates leptin-regulated bone formation.
    Fu L; Patel MS; Bradley A; Wagner EF; Karsenty G
    Cell; 2005 Sep; 122(5):803-15. PubMed ID: 16143109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The control of bone remodeling by neuropeptide Y receptors.
    Allison SJ; Baldock PA; Herzog H
    Peptides; 2007 Feb; 28(2):320-5. PubMed ID: 17197054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of leptin on bone mineral dencity in premenopausal and postmenopausal women].
    Shanava Sh; Zerekidze T; Amashukeli M; Asatiani Q
    Georgian Med News; 2011 May; (194):47-52. PubMed ID: 21685522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin and bone metabolism.
    Coen G
    J Nephrol; 2004; 17(2):187-9. PubMed ID: 15293517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central control of bone remodeling by neuromedin U.
    Sato S; Hanada R; Kimura A; Abe T; Matsumoto T; Iwasaki M; Inose H; Ida T; Mieda M; Takeuchi Y; Fukumoto S; Fujita T; Kato S; Kangawa K; Kojima M; Shinomiya K; Takeda S
    Nat Med; 2007 Oct; 13(10):1234-40. PubMed ID: 17873881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genomic approaches to bone and joint diseases. Control of bone remodeling by hormones and neuronal pathways].
    Takeda S
    Clin Calcium; 2008 Feb; 18(2):216-21. PubMed ID: 18245892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow.
    Hamrick MW; Della Fera MA; Choi YH; Hartzell D; Pennington C; Baile CA
    Cell Tissue Res; 2007 Jan; 327(1):133-41. PubMed ID: 17024416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular bases of the sympathetic regulation of bone mass.
    Takeda S; Karsenty G
    Bone; 2008 May; 42(5):837-40. PubMed ID: 18295563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central control of bone remodeling.
    Takeda S
    Biochem Biophys Res Commun; 2005 Mar; 328(3):697-9. PubMed ID: 15694403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is leptin the link between fat and bone mass?
    Isaia GC; D'Amelio P; Di Bella S; Tamone C
    J Endocrinol Invest; 2005; 28(10 Suppl):61-5. PubMed ID: 16550725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of innervation in the control of bone remodeling.
    Chenu C
    J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):132-4. PubMed ID: 15615111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin increases proliferation of human steosarcoma cells through activation of PI(3)-K and MAPK pathways.
    Burguera B; Brunetto A; Garcia-Ocana A; Teijeiro R; Esplen J; Thomas T; Couce ME; Zhao A
    Med Sci Monit; 2006 Nov; 12(11):BR341-9. PubMed ID: 17072262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential osteogenic effects of systemic leptin and insulin administration in streptozotocin-induced diabetic female rats.
    Gad HI
    Saudi Med J; 2007 Aug; 28(8):1185-90. PubMed ID: 17676199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new field of neuroskeletal biology.
    Patel MS; Elefteriou F
    Calcif Tissue Int; 2007 May; 80(5):337-47. PubMed ID: 17440766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A neuro (endo)crine regulation of bone remodeling.
    Amling M; Takeda S; Karsenty G
    Bioessays; 2000 Nov; 22(11):970-5. PubMed ID: 11056473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
    Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
    Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin and cardiovascular diseases.
    Luo JD; Zhang GS; Chen MS
    Drug News Perspect; 2005 Sep; 18(7):427-31. PubMed ID: 16362081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin in end stage renal disease (ESRD): a link between fat mass, bone and the cardiovascular system.
    Mallamaci F; Tripepi G; Zoccali C
    J Nephrol; 2005; 18(4):464-8. PubMed ID: 16245256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.